Drug pipeline 2016
The most helpful thing anyone can do for a mother in this situation is give her the actual evidence, clearly presented, so she can make an informed decision with her physician
GLP-1 receptor agonists are well-established for their appetite-suppressing effects, which contribute significantly to their weight loss benefits
Increases and restores telomere length: Peer-reviewed research has demonstrated Epithalons ability to induce telomere elongation in human somatic cells
With retatrutide specifically, improvements in fasting glucose, HbA1c, triglycerides, and liver enzymes were observed within the first 12 to 16 weeks of treatment across all dose groups
Commonly reported side effects include: Nausea, vomiting, and diarrhoea particularly during dose escalation Constipation and abdominal discomfort Decreased appetite and early satiety Injection site reactions (mild and transient) Fatigue, especially in the initial weeks of treatment These gastrointestinal effects are consistent with the GLP-1 mechanism and are generally dose-dependent and transient